KOBO (2)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE announces transfer of 30 scrips to 'Z'/'MT' group effective December 12, 2025, due to non-compliance with annual report filing … | |||||||||||||||
BSE announces transfer of 30 scrips to 'Z'/'MT' group effective December 12, 2025, due to non-compliance with annual report filing requirements for FY 2024 and FY 2025.
| |||||||||||||||
BSE updates surveillance measures for companies under Insolvency and Bankruptcy Code (IBC), with Kobo Biotech Ltd moved to Stage 1 effective … | |||||||||||||||
BSE updates surveillance measures for companies under Insolvency and Bankruptcy Code (IBC), with Kobo Biotech Ltd moved to Stage 1 effective October 30, 2025.
| |||||||||||||||